Karyopharm Therapeutics (KPTI) Misses Q2 EPS by 5c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. NVDA
3. CRM
4. USO
5. FLNC
6. QQQ
7. ON
8. GNRC
9. INTC
10. META

Go back to Karyopharm Therapeutics (KPTI) Misses Q2 EPS by 5c, Revenues Beat
KARYOPHARM THERAP (NASDAQ: KPTI) Delayed: 1.70 --0 (-0%)
Previous Close $1.70    52 Week High $19.41 
Open $1.70    52 Week Low $4.83 
Day High $1.70    P/E N/A 
Day Low $1.70    EPS $-2.74 
Volume 570